C/A 0001787792 XXXXXXXX 020-37002 LIVE false false false false Amendment to the closing date (July 31 to Sept 16). Amendment to the coupon code perk (applicable to all investors in the round). Fisher Wallace Laboratories, Inc. Corporation DE 08-23-2019 630 FLUSHING AVENUE, BOX 104 BROOKLYN NY 11206 fisherwallace.com N DEALMAKER SECURITIES LLC 0001872856 008-70756 000315324 Up to 8.5% Common Stock 900 11.30000 10525.95 Y Other At the discretion of the Company 4398747.72 07-31-2026 3.00 144634.00 154382.00 48142.00 41626.00 0.00 0.00 591311.00 596721.00 693612.00 925582.00 34261.00 47412.00 5049.00 3012.00 0.00 0.00 -1447538.00 -1579900.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 Fisher Wallace Laboratories, Inc. /Kelly Roman/ Chief Executive Officer and Director /Kelly Roman/ Chief Executive Officer and Director 07-15-2026